176 related articles for article (PubMed ID: 38132381)
21. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
22. FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
Sheikhbahaei S; Trahan TJ; Xiao J; Taghipour M; Mena E; Connolly RM; Subramaniam RM
Oncologist; 2016 Aug; 21(8):931-9. PubMed ID: 27401897
[TBL] [Abstract][Full Text] [Related]
23. Decision making in borderline ovarian tumors: report of a rare case of mesosigma psammocarcinoma.
Grimaldi L; Danzi M; Reggio S; Pannullo M; Danzi R; Lauria R
Ann Ital Chir; 2013 Sep; 84(ePub):. PubMed ID: 23995281
[TBL] [Abstract][Full Text] [Related]
24. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
25. Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC): a phase II prospective trial.
Verghote F; Poppe L; Verbeke S; Dirix P; Albersen M; De Meerleer G; Berghen C; Ost P; Villeirs G; De Visschere P; De Man K; De Maeseneer D; Rottey S; Van Praet C; Decaestecker K; Fonteyne V
BMC Cancer; 2021 Oct; 21(1):1113. PubMed ID: 34663254
[TBL] [Abstract][Full Text] [Related]
26. The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer.
Kahn D; Menda Y; Kernstine K; Bushnell D; McLaughlin K; Miller S; Berbaum K
Chest; 2004 Feb; 125(2):494-501. PubMed ID: 14769730
[TBL] [Abstract][Full Text] [Related]
27. Prognostic importance of peritoneal lesion-to-primary tumour standardized uptake value ratio in advanced serous epithelial ovarian cancer.
Chung HH; Kim JW; Park NH; Song YS; Cheon GJ
Eur Radiol; 2018 May; 28(5):2107-2114. PubMed ID: 29260365
[TBL] [Abstract][Full Text] [Related]
28. Prospective study evaluating the relative sensitivity of 18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and 99mTc-MDP bone scintigraphy, using an adaptive trial design.
Gerety EL; Lawrence EM; Wason J; Yan H; Hilborne S; Buscombe J; Cheow HK; Shaw AS; Bird N; Fife K; Heard S; Lomas DJ; Matakidou A; Soloviev D; Eisen T; Gallagher FA
Ann Oncol; 2015 Oct; 26(10):2113-8. PubMed ID: 26202597
[TBL] [Abstract][Full Text] [Related]
29. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
Kim CK; Park BK; Choi JY; Kim BG; Han H
J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Positron Emission Tomography Using 2-[18F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[18F]-fluorothymidine in Lung Cancer Imaging.
Wang FL; Tan YY; Gu XM; Li TR; Lu GM; Liu G; Huo TL
Chin Med J (Engl); 2016 Dec; 129(24):2926-2935. PubMed ID: 27958224
[TBL] [Abstract][Full Text] [Related]
31. Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study.
Zattoni F; Incerti E; Colicchia M; Castellucci P; Panareo S; Picchio M; Fallanca F; Briganti A; Moschini M; Gallina A; Karnes JR; Lowe V; Fanti S; Schiavina R; Rambaldi I; Ficarra V; Evangelista L
Abdom Radiol (NY); 2018 Sep; 43(9):2391-2399. PubMed ID: 29302738
[TBL] [Abstract][Full Text] [Related]
32. Value of FDG PET/CT in patients with treated ovarian cancer and raised CA125 serum levels.
Palomar A; Nanni C; Castellucci P; Ambrosini V; Montini GC; Allegri V; Pettinato C; Al-Nahhas A; Soriano A; Grassetto G; Rubello D; Fanti S
Mol Imaging Biol; 2012 Feb; 14(1):123-9. PubMed ID: 21240639
[TBL] [Abstract][Full Text] [Related]
33. Diversity of imaging features of ovarian sclerosing stromal tumors on MRI and PET-CT: a case report and literature review.
Matsutani H; Nakai G; Yamada T; Yamamoto K; Ohmichi M; Narumi Y
J Ovarian Res; 2018 Dec; 11(1):101. PubMed ID: 30572921
[TBL] [Abstract][Full Text] [Related]
34. Utility of 18F-FDG PET/CT in follow-up of patients with low-grade serous carcinoma of the ovary.
Takeuchi S; Lucchini M; Schmeler KM; Coleman RL; Gershenson DM; Munsell MF; Macapinlac HA; Ramirez PT
Gynecol Oncol; 2014 Apr; 133(1):100-4. PubMed ID: 24534359
[TBL] [Abstract][Full Text] [Related]
35. Normal-sized ovary carcinoma syndrome (NOCS) detected with FDG-PET/CT.
Kanda M; Sonoyama A; Ohara N
Eur J Gynaecol Oncol; 2014; 35(5):597-9. PubMed ID: 25423714
[TBL] [Abstract][Full Text] [Related]
36. Ovarian dysgerminoma detected by 18F-FDG PET/CT technique: A case report.
Wang P; Feng Y; Dai W; Pu Q
Medicine (Baltimore); 2020 Nov; 99(45):e23074. PubMed ID: 33157971
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic significance of MRI versus CT using identical PET data in patients with recurrent differentiated thyroid cancer: A PET/MRI study.
Westphal K; Eiber M; Henninger M; Scheidhauer K; Beer AJ; Thaiss W; Rischpler C
Medicine (Baltimore); 2023 Apr; 102(16):e33533. PubMed ID: 37083773
[TBL] [Abstract][Full Text] [Related]
38. Cancer Patient Experience in a Nuclear Medicine Department: Comparison Between Bone Scintigraphy and
Grilo AM; Vieira L; Carolino E; Costa M; Galaio S; Melo I; Geão A; Santos A; Colarinha P
J Nucl Med Technol; 2020 Sep; 48(3):254-262. PubMed ID: 32518119
[TBL] [Abstract][Full Text] [Related]
39. Serous psammocarcinoma of the ovary: an unusual finding.
Rettenmaier MA; Goldstein BH; Epstein HD; Brown JV; Micha JP
Gynecol Oncol; 2005 Nov; 99(2):510-1. PubMed ID: 16051342
[TBL] [Abstract][Full Text] [Related]
40. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]